Ketoconazole 2% foam for treatment of seborrheic dermatitis

Expert Review of Dermatology

Volumn 3, Issue 1, 2008, Pages 15-21

  Rolz Cruz, Gabriela ^a   Kimball, Alexa B ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Clinical Unit for Research Trials in Skin   (United States)

Author keywords

Clinical trials; Dermatitis; Foam; Ketoconazole; Seborrheic

Indexed keywords

ALLYLAMINE DERIVATIVE; ANTIFUNGAL AGENT; BENZYLAMINE DERIVATIVE; BUTENAFINE; CALCINEURIN INHIBITOR; CICLOPIROXOLAMINE; CORTICOSTEROID; EXTINA; KETOCONAZOLE; PIMECROLIMUS; PLACEBO; PYRIDINOLINE; PYRITHIONE ZINC; PYRROLE; SALICYLIC ACID; SELENIUM SULFIDE; STEROID; TACROLIMUS; TAR; TERBINAFINE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; APPLICATION SITE BURNING; APPLICATION SITE PRURITUS; APPLICATION SITE REACTION; ARTICLE; CLINICAL TRIAL; DANDRUFF; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; FUNGAL DETECTION; HEADACHE; HUMAN; MALASSEZIA; MYCOSIS; PHOTOALLERGY; PRIORITY JOURNAL; SEBORRHEIC DERMATITIS; SKIN ATROPHY; STRUCTURE ANALYSIS; TELANGIECTASIA; THERMOSTABILITY;

EID: 40749099692     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/17469872.3.1.15     Document Type: Article

References (21)

1. Gupta AK, Mphil RB, Bluhm R, Boekhout T, Dawson TL. Skin diseases associated with Malassezia species. J. Am. Acad Dermatol. 51(5), 785-798 (2004).
2. Altmeyer P, Hoffman K. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial. Int. Soc. Dermatol. 43(Suppl. 1), 9-12 (2004).
3. Dreno B, Chosidow O, Revuz J, Moyse D. Lithium gluconate 8% vs. ketoconazole 2% in the treatment of seborrheic dermatitis: a multicentre, randomized study. Br. J. Dermatol. 148(6), 1230-1236 (2003).
4. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrheic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br. J. Dermatol. 132(3), 441-445 (1995).
5. DeAngelis YM, Gemmer CM, Kaczvinscky JR, Kenneally DC, Schwartz JR, Dawson TL. Three etiologic facets of dandruff and seborrheic dermatitis: Malassezia fungi, sebaceous lipids, and individual sensitivity. J. Investig. Dermatol. Symp. Proc. 10(3Y, 295-297 (2005).
6. Gupta AY, Nicol K, Batra R. Role of antifungal agents in the treatment of seborrheic dermatitis. Am. J Clin. Dermatol. 5(6), 417-422 (2004).
7. Gueho E, Midgley G, Guillot J. The genus Malassezia with description of four new species. Antonie van Leeuwenhoek 69(4), 337-355 (1996).
8. Sugita T, Suto H, Unno T et al. Molecular analysis of malassezia microflora on the skin of atopic dermatitis patients and healthy subjects. J. Clin Microbiol. 39(10), 3486-3490 (2001).
9. Ro BI, Dawson TL. The role of sebaceous gland activity and scalp microfloral metabolism in the etiology of seborrheic dermatitis and dandruff. J. Investig. Dermatol. Symp. Proc. 10(3), 194-197 (2005).
10. Draeolos ZD, Keneally DC, Hodges LT, Billhimer W, Copas M, Margraf C. A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos. J. Investig. Dermatol. Symp. Proc. 10(3), 201-204 (2005).
11. Gupta AK, Nicol KA. Ciclopirox 1% shampoo for the treatment of seborrheic: dermatitis. Int. J. Dermatol. 45(1), 66-69 (2006).
12. Deng H, Tanojo H, Lenn J. Foam as a novel vehicle in topical therapy. J. Am. Acad. Dermatol. 50(Suppl. 3) P80 (2004).
13. Huang X, Tanojo H, Lenn J, Deng H, Krochmal L. A novel foam vehicle for delivery of topical corticosteroids. J. Am. Acad. Dermatol. 53(1 Suppl. 1), S26-S38 (2005).
14. Ford GP, Farr PM, Ive FA, Shuster S. The response of seborrheic dermatitis to ketoconazole. Br. J. Dermatol. 111(5), 603-607 (1984).
15. Skinner RB, Rosenberg EW. Double-blind treatment of seborrheic dermatitis with ketoconazole cream. J. Am. Acad. Dermatol. 12 (5 Pt. 1), 852-856 (1985).
16. Carr MM, Pryce DM, Ive FA. Treatment of seborrhoeic dermatitis with ketoconazole: response of seborrhoeic dermatitis of the scalp to topical ketoconazole. Br. J. Dermatol. 116(2), 213-216 (1981)
17. Pierard GE, Pierard-Franchimont C, Van Custem J, Rurangirwa A, Hoppenbrowers ML, Schroolen P. Ketoconazole 2% emulsion in the treatment of seborrheic dermatitis. Int. J. Dermatol. 30(11), 806-809 (1991).
18. Pierard-Franchimont C, Pierard GE. A double blind, placebo-controlled study of ketoconazole plus desonide gel combination in the treatment of facial seborrheic dermatitis. Dermatology 204(4), 344-347 (2002).
19. Elewski B, Ling MR, Phillips TJ. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a Phase III trial. J. Drugs Dermatol. 5(7), 646-650 (2006).
20. Elewski BE, Abramovits W, Kempers S et al. A novel foam formulation of ketoconazole, 2%, in the treatment of seborrheic dermatitis on all areas of the body. J. Drugs Dermatol. 6(10), 1001-1008 (2007).
21. Koller T, Spellman M, Yaroshinsky A, Elewski BE. A randomized, double-blind, double-dummy, placebo-controlled study of the safety and efficacy of ketoconazole foam 2% versus ketoconazole 2% cream in the treatment of seborrheic dermatitis. J. Am. Acad. Dermatol. 50(3 Suppl. 1), P103 (2004)